Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Celletti

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Reumatismo|January 27, 2025
Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature reviewEleonora Celletti, Giulio Gualdi, Emanuela Sabatini, et al.
Minerva Endocrinology|April 5, 2024
Safety and effects of calcifediol 0.266 milligrams soft capsules monthly and cholecalciferol 25000 international units monthly in osteoporotic women undergoing therapy with alendronate: a cross-sectional studyEmiliano Giampà, Eleonora Celletti, Mario DI Bonito, et al.
Nutrients|October 23, 2021
Improvement of Inflammation and Pain after Three Months' Exclusion Diet in Rheumatoid Arthritis PatientsMaria Teresa Guagnano, Chiara D'Angelo, Daniela Caniglia, et al.
Immunity, Inflammation and Disease|January 19, 2021
Efficacy of canakinumab in mild or severe COVID-19 pneumoniaKatia Falasca, Myriam Di Penta, Claudio Ucciferri, et al.
Arthritis Care & Research|November 12, 2015
Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus InfectionMelissa Padovan, Matteo Filippini, Angela Tincani, et al.
Rheumatology and Therapy|March 4, 2024
The Evaluation of Effectiveness and Safety of Guselkumab in Patients with Psoriatic Arthritis in a Prospective Multicentre "Real-Life" Cohort StudyPiero Ruscitti, Giulia Cataldi, Martina Gentile, et al.
RMD Open|March 24, 2026
Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the 'AIRE' multicentre studyValentino Paci, Alen Zabotti, Alessandro Fontanarosa, et al.
Clinical and Experimental Rheumatology|July 27, 2023
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohortPiero Ruscitti, Ilenia Pantano, Fabio Massimo Perrotta, et al.
Microorganisms|November 19, 2020
Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in ItalyMarco Canzoni, Massimo Marignani, Maria Laura Sorgi, et al.
Rheumatology and Therapy|April 12, 2026
Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational StudyCaterina Baldi, Eleonora Celletti, Serena Bugatti, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Reumatismo|January 27, 2025
Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature reviewEleonora Celletti, Giulio Gualdi, Emanuela Sabatini, et al.
Minerva Endocrinology|April 5, 2024
Safety and effects of calcifediol 0.266 milligrams soft capsules monthly and cholecalciferol 25000 international units monthly in osteoporotic women undergoing therapy with alendronate: a cross-sectional studyEmiliano Giampà, Eleonora Celletti, Mario DI Bonito, et al.
Nutrients|October 23, 2021
Improvement of Inflammation and Pain after Three Months' Exclusion Diet in Rheumatoid Arthritis PatientsMaria Teresa Guagnano, Chiara D'Angelo, Daniela Caniglia, et al.
Immunity, Inflammation and Disease|January 19, 2021
Efficacy of canakinumab in mild or severe COVID-19 pneumoniaKatia Falasca, Myriam Di Penta, Claudio Ucciferri, et al.
Arthritis Care & Research|November 12, 2015
Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus InfectionMelissa Padovan, Matteo Filippini, Angela Tincani, et al.
Rheumatology and Therapy|March 4, 2024
The Evaluation of Effectiveness and Safety of Guselkumab in Patients with Psoriatic Arthritis in a Prospective Multicentre "Real-Life" Cohort StudyPiero Ruscitti, Giulia Cataldi, Martina Gentile, et al.
RMD Open|March 24, 2026
Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the 'AIRE' multicentre studyValentino Paci, Alen Zabotti, Alessandro Fontanarosa, et al.
Clinical and Experimental Rheumatology|July 27, 2023
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohortPiero Ruscitti, Ilenia Pantano, Fabio Massimo Perrotta, et al.
Microorganisms|November 19, 2020
Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in ItalyMarco Canzoni, Massimo Marignani, Maria Laura Sorgi, et al.
Rheumatology and Therapy|April 12, 2026
Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational StudyCaterina Baldi, Eleonora Celletti, Serena Bugatti, et al.
Pageof 3